International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, cilt.103, ss.599-606, 2021 (SCI-Expanded, Scopus)
BACKGROUND & AIMS: Hydroxychloroquine (HCQ) and chloroquine (CQ) are anti-malarial drugs frequently used in the rheumatologic field. They were recently identified as potential therapeutic options for Coronavirus Disease (COVID-19). The present study aims to map and grade the diverse health outcomes associated with HCQ/CQ using an umbrella review approach.